Home / Dabigatran Etexilate / Italy
IT ATC B01AE07 · updated 2 Nov 2026
Dabigatran Etexilate shortage in Italy
Is there a Dabigatran Etexilate shortage in Italy?
Yes. As of 2 Nov 2026, 9 Dabigatran Etexilate products are reported short in Italy, the first since 2 Jan 2026. The company estimate for the return is 31 Dec 2026 (latest 28 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | DABIGATRAN ETEXILATO MEDICAL VALLEY | MEDICAL VALLEY INVEST AB | 2 Jan 2026 | 31 Dec 2026 | Increased demand Elevata richiesta/problemi produttivi (carenza relativa solo al canale ospedaliero) |
| IT | DABIGATRAN ETEXILATO MEDICAL VALLEY | MEDICAL VALLEY INVEST AB | 1 May 2026 | 31 Dec 2026 | Increased demand Elevata richiesta/problemi produttivi (carenza relativa solo al canale ospedaliero) |
| IT | DABIGATRAN ETEXILATO VIATRIS | MYLAN S.P.A. | 15 May 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DABIGATRAN ETEXILATO ACCORD | ACCORD HEALTHCARE, S.L.U. | 22 Jul 2026 | not given | Increased demand Elevata richiesta |
| IT | DABIGATRAN ETEXILATO VIATRIS | MYLAN S.P.A. | 10 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DABIGATRAN ETEXILATO VIATRIS anticipated | MYLAN S.P.A. | 20 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | DABIGATRAN ETEXILATO TEVA anticipated | TEVA GMBH | 7 Dec 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | DABIGATRAN ETEXILATO TEVA anticipated | TEVA GMBH | 7 Dec 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | DABIGATRAN ETEXILATO TEVA anticipated | TEVA GMBH | 7 Dec 2026 | 28 Feb 2027 | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.